Mutation in TP53 is the most common genetic change in HCC, and patients with mutated TP53 have shorter OS than those with wild-type TP53. Therefore, we conducted special subgroup analyses stratifying samples according to the combination of TP53 mutation status and riskgroups. The gene discussed is TP53; the disease is hepatocellular carcinoma.